114 STAT. 2320
PUBLIC LAW 106-505—NOV. 13, 2000
"(4) the sequencing of the genomes of priority pathogens
as determined by the Director of the National Institutes of
Health in consultation with the task force established under
subsection (a); and
"(5) other relevant research areas.
"(c) EDUCATION OF MEDICAL AND PUBLIC HEALTH PERSONNEL.—
The Secretary, after consultation with the Assistant Secretary for
Health, the Surgeon General, the Director of the Centers for Disease
Control and Prevention, the Administrator of the Health Resources
and Services Administration, the Director of the Agency for
Healthcare Research and Qusility, members of the task force
described in subsection (a), professional organizations and societies,
and such other public health officials as may be necessary, shall—
"(1) develop and implement educational programs to
increase the awareness of the general public with respect to
the public health threat of antimicrobial resistance and the
appropriate use of antibiotics;
"(2) develop and implement educational programs to
instruct health care professionals in the prudent use of antibiotics; and
"(3) develop and implement programs to train laboratory
personnel in the recognition or identification of resistance in
pathogens.
"(d) GRANTS.—
"(1) IN GENERAL.— The Secretary shall award competitive
grants to eligible entities to enable such entities to increase
the capacity to detect, monitor, and combat antimicrobial resistance.
"(2) ELIGIBLE ENTITIES. —Eligible entities for grants under
paragraph (1) shall be State or local public health agencies,
Indian tribes or tribal organizations, or other public or private
nonprofit entities.
"(3) USE OF FUNDS. — An eligible entity receiving a grant
under paragraph (1) shall use funds from such grant for activities that are consistent with the factors identified by the task
force under subsection (a)(3), which may include activities
that—
"(A) provide training to enable such entity to identify
patterns of resistance rapidly and accurately;
"(B) develop, improve, coordinate or enhance participation in information systems by which data on resistant
infections can be shared rapidly among relevant national,
State, and local health agencies and health care providers;
and
"(C) develop and implement policies to control the
spread of antimicrobial resistance.
"(e) GRANTS FOR DEMONSTRATION PROGRAMS.—
"(1) IN GENERAL. — The Secretary shall award competitive
grants to eligible entities to establish demonstration programs
to promote judicious use of antimicrobial drugs or control the
spread of antimicrobial-resistant pathogens.
"(2) ELIGIBLE ENTITIES. — Eligible entities for grants under
paragraph (1) may include hospitals, clinics, institutions of
long-term care, professional medical societies, or other public
or private nonprofit entities.
�
